Celyad SA Gains 25%

Thu, May 19, 2022 at 05:30 PM
Celyad SA Gains 25%

Celyad SA (CYAD:NASDAQ) rocketted at $1.93, a gain of 25%. The stock got featured on our News Catalysts scanner on Tue, May 17, 2022 at 05:22 PM in the 'MISCELLANEOUS' category. From Wed, May 04, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days

The stock spiked on Fri, Dec 03, 2021 at $5.32 with a volume of 56M+.

About Celyad SA (CYAD:NASDAQ)

Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.